{
  "trial_id": "NCT03258476",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Lifetime history of traumatic stress documented by self and/or caregiver response on the youth self-report and or caregiver-report Structured Trauma-Related Experiences & Symptoms Screener (STRESS) (i.e., at least one yes response on STRESS items 1-25).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "A baseline STRESS total score \u2265 21 for females or a baseline STRESS total score \u2265 17 for males (STRESS items # 26-48: range of total scores: 0-69) 68 as completed by caregiver OR youth.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Assent of child and consent of both parents/caregivers.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Living with a caregiver legally empowered to permit study enrollment and able to complete protocol assessments.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "English speaking.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "A history of cardiovascular disease, previous history of ECG abnormalities, syncope, exercise-induced cardiovascular symptoms, or any other unstable medical illness/allergy (i.e., seizure disorder) that in the opinion of the site Medical Director precludes enrollment in the study.",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "Autistic disorder, persons with intellectual disability (IQ \u2264 70), clinically significant (in the judgment of the site Medical Director) substance abuse disorder (within the past 30 days), bipolar I disorder, schizophrenia or other psychotic disorder, or major depressive disorder with symptoms that are severe enough (e.g. suicidality) that in the opinion of the site Medical Director excludes study participation.",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "Concomitant Medications: Use of other psychiatric medications including extended release guanfacine (study drug) besides a stable dose of stimulants or atomoxetine for ADHD for the study duration is exclusionary for this protocol. All other medications will undergo discontinuation.",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients who are unable to comply with the study protocol.",
      "label": "triggers",
      "evidence": "unknown"
    }
  ],
  "notes": "The patient has a history of cardiovascular disease and is taking other psychiatric medications, which may preclude enrollment in the study.",
  "_meta": {
    "topic_id": "49",
    "trial_id": "NCT03258476",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}